The United Kingdom has released comprehensive data showing which institutions have failed to register their clinical trials, a move that was hailed by transparency advocates who say this marks the first time that a country has taken such a step.
Last week, the Health Research Authority posted complete registration information for 1,545 trials, including the name of the study, the sponsor, and registration number for the trial. Until now, the agency had provided only annual snapshots showing the proportion of trials that are registered, and had not previously published registration information on a trial-by-trial basis.
The findings were notable. In 2022, 92% of the trials had been registered. More than nine out of 10 clinical trials met their registration requirements, which was an increase from previous years. And for almost all of the registered clinical trials, the sponsor had informed the HRA it was registered. Two-thirds of the trials, by the way, were registered on ClinicalTrials.gov, the U.S. database.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect